BRILLANTI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 656
NA - Nord America 606
AS - Asia 177
OC - Oceania 49
AF - Africa 36
SA - Sud America 8
Totale 1.532
Nazione #
US - Stati Uniti d'America 566
NL - Olanda 327
GB - Regno Unito 101
IT - Italia 94
CN - Cina 51
AU - Australia 48
CA - Canada 39
JP - Giappone 30
FR - Francia 29
EG - Egitto 24
HK - Hong Kong 24
IE - Irlanda 24
DE - Germania 19
IN - India 15
ES - Italia 12
DK - Danimarca 10
VN - Vietnam 10
CH - Svizzera 8
SE - Svezia 8
PK - Pakistan 7
SG - Singapore 6
IR - Iran 5
TR - Turchia 5
AT - Austria 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
AR - Argentina 3
BE - Belgio 3
DZ - Algeria 3
KR - Corea 3
PL - Polonia 3
PS - Palestinian Territory 3
PT - Portogallo 3
UG - Uganda 3
CL - Cile 2
FI - Finlandia 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
JO - Giordania 2
LK - Sri Lanka 2
TW - Taiwan 2
BG - Bulgaria 1
BR - Brasile 1
BW - Botswana 1
BY - Bielorussia 1
ID - Indonesia 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
QA - Qatar 1
RO - Romania 1
SR - Suriname 1
TH - Thailandia 1
TN - Tunisia 1
Totale 1.532
Città #
Amsterdam 322
Siena 61
Fairfield 55
Seattle 43
Ashburn 39
Sydney 32
Houston 27
Buffalo 26
Dublin 24
Woodbridge 24
Cambridge 22
Central 22
Los Angeles 18
Wilmington 18
London 16
Santa Cruz 16
Chicago 13
Tokyo 13
Ottawa 12
Kansas City 10
Melbourne 10
New York 10
Dong Ket 9
Liverpool 9
Lubbock 9
Toronto 9
Bristol 8
Los Altos 8
Umeda 8
Ann Arbor 7
Giza 7
Manchester 7
San Jose 7
South Shields 7
Frederiksberg 6
Middlesbrough 6
Sherman Oaks 6
Stockholm 6
Barcelona 5
Brest 5
Cairo 5
Cleveland 5
Henderson 5
Lambeth 5
Minusio 5
Naples 5
San Diego 5
Southend 5
El Paso 4
Elk Grove 4
Eye 4
Hamilton 4
Hickory Hills 4
Las Vegas 4
Lee's Summit 4
Milan 4
Perth 4
Shanghai 4
Wuhan 4
Americus 3
Atlanta 3
Bengaluru 3
Berlin 3
Boardman 3
Bryant 3
Cesenatico 3
Chennai 3
Chepstow 3
Chiyoda-ku 3
Grenoble 3
Hangzhou 3
Indianapolis 3
Istanbul 3
Kampala 3
Kochi 3
Lake Forest 3
Lexington 3
Muizenberg 3
Nottingham 3
Pasadena 3
Peshawar 3
Raleigh 3
Riyadh 3
San Francisco 3
Southborough 3
Tilburg 3
Vienna 3
Aarhus 2
Amman 2
An Nuzhah al Jadidah 2
Athens 2
Baltimore 2
Barnsley 2
Beijing 2
Berkeley 2
Bologna 2
Brisbane 2
Budapest 2
Buenos Aires 2
Chongqing 2
Totale 1.156
Nome #
Primary Biliary cholangitis case-finding: an italian multicenter observational study on patients with incidental finding of anti-mithocondrial antibodies, file 9fb1d1ce-1a28-46c3-979a-c5aed4cab19e 605
null, file ffb7559d-b32a-490b-a1f1-2453817a3ff6 299
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum, file e0feeaa7-ea28-44d2-e053-6605fe0a8db0 156
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pylori in dyspeptic patients, file e0feeaa7-f9d0-44d2-e053-6605fe0a8db0 148
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients, file e0feeaa7-c98d-44d2-e053-6605fe0a8db0 93
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals, file e0feeaab-d102-44d2-e053-6605fe0a8db0 92
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older, file e0feeaab-e252-44d2-e053-6605fe0a8db0 49
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals, file e0feeaab-c242-44d2-e053-6605fe0a8db0 44
Management of Delta Hepatitis 45 years after the discovery of HDV, file f5e79690-b558-479d-87ca-df68bb47792a 11
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals, file e0feeaa7-f954-44d2-e053-6605fe0a8db0 5
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project, file 9284569c-3d8a-43d1-94f1-c9c5600eeb8e 4
Ribavirin for chronic hepatitis C: And the mystery goes on, file e0feeaa7-eb60-44d2-e053-6605fe0a8db0 4
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals, file e0feeaa7-c98f-44d2-e053-6605fe0a8db0 3
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study, file e0feeaa7-ea2a-44d2-e053-6605fe0a8db0 3
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3, file e0feeaa7-ea2b-44d2-e053-6605fe0a8db0 3
Role of amantadine and other adjuvant therapies in the treatment of hepatitis C, file e0feeaa7-ea2e-44d2-e053-6605fe0a8db0 3
LONG-TERM PERSISTENCE OF IGM ANTIBODIES TO HCV IN CHRONIC HEPATITIS-C, file e0feeaa7-f895-44d2-e053-6605fe0a8db0 3
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis, file e0feeaa7-c996-44d2-e053-6605fe0a8db0 2
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study, file e0feeaa7-ea29-44d2-e053-6605fe0a8db0 2
Severe acute autoimmune hepatitis after natalizumab treatment, file e0feeaa7-ea2c-44d2-e053-6605fe0a8db0 2
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients, file e0feeaa7-ea2f-44d2-e053-6605fe0a8db0 2
What hides behind an intention-to-treat analysis?, file e0feeaa7-f650-44d2-e053-6605fe0a8db0 2
Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders, file e0feeaa7-f898-44d2-e053-6605fe0a8db0 2
Serum IgM antibodies to hepatitis C virus in acute and chronic hepatitis C, file e0feeaa7-f8ad-44d2-e053-6605fe0a8db0 2
Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis, file e0feeaa7-f919-44d2-e053-6605fe0a8db0 2
Whipple's disease with melaena and multiple petechial haemorrhages in duodenal mucosa, file e0feeaa7-f9c9-44d2-e053-6605fe0a8db0 2
Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 49 5 patients with chronic hepatitis C, file e0feeaa7-f9cd-44d2-e053-6605fe0a8db0 2
Persistent hepatitis C viraemia without liver disease, file e0feeaa7-c9a6-44d2-e053-6605fe0a8db0 1
Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu vaccinations, file e0feeaa7-eb5f-44d2-e053-6605fe0a8db0 1
Peginterferon-based therapy for chronic hepatitis C virus infection in patients with normal alanine aminotransferase levels, file e0feeaa7-f12c-44d2-e053-6605fe0a8db0 1
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens, file e0feeaa7-f12e-44d2-e053-6605fe0a8db0 1
Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C, file e0feeaa7-f8a2-44d2-e053-6605fe0a8db0 1
Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience, file e0feeaa7-f95d-44d2-e053-6605fe0a8db0 1
Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis, file e0feeaa7-f961-44d2-e053-6605fe0a8db0 1
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals, file e0feeaa8-09c2-44d2-e053-6605fe0a8db0 1
Totale 1.553
Categoria #
all - tutte 2.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201935 0 0 0 0 0 0 0 0 0 0 20 15
2019/2020117 9 6 5 11 8 14 18 13 15 4 8 6
2020/2021113 4 8 3 26 8 8 7 9 5 10 6 19
2021/202265 4 4 0 1 8 2 2 3 4 2 25 10
2022/2023507 11 28 24 22 26 22 25 40 81 86 74 68
2023/2024660 20 23 28 41 48 293 96 55 9 47 0 0
Totale 1.553